Vision, Год журнала: 2025, Номер 9(2), С. 35 - 35

Опубликована: Апрель 17, 2025

Retina, a light-sensitive layer of tissue the eye, requires high levels oxygen for its physiology. Retinal ischemia occurs due to inadequate supply blood retina and choroid. is implicated in development or progression many ocular diseases, such as diabetic retinopathy (DR) age-related macular degeneration (AMD). To date, anti-vascular endothelial growth factor (VEGF) treatment has been widely used manage neovascular diseases associated with retinal ischemia. Nonetheless, substantial number patients DR AMD still suffer from incomplete response adverse effects related therapy limitations. Therefore, research scientists have developing finding novel treatments protect against prevent vision loss those diseases. In this review article, we summarize recent therapeutic approaches ischemic (e.g., cell therapy, advanced molecular targeting, drug delivery). This summary enables further obtain more solid evidence effective

Язык: Английский